Jakarta, October 5, 2025 — PT Advance Medicare Corpora participated in an international event titled “Collaborative Innovations in Maternal Fetal Medicine”, a joint collaboration between RSAB Harapan Kita and University College London Hospitals (UCLH) London, held on October 4–7, 2025, at JW Marriott Hotel Jakarta and RSAB Harapan Kita. This event marks a significant milestone in strengthening global collaboration in the field of maternal-fetal medicine — a medical discipline focused on managing high-risk pregnancies and treating fetuses with complex medical conditions.

The event opened with the International Symposium on October 4–5, 2025, at JW Marriott Jakarta, featuring leading fetomaternal experts from UCLH London, RSAB Harapan Kita, and various national medical institutions. The scientific discussions during the symposium explored the latest advancements in early diagnosis, fetal intervention, and high-risk pregnancy management, including the use of cutting-edge medical technologies to enhance the safety of both mothers and babies.

The series of events continued with a number of clinical workshops held at the RSAB Harapan Kita Auditorium. On October 5, the Twin to Twin Transfusion Syndrome (TTTS) Workshop was conducted, focusing on managing pregnancy complications in twin fetuses. This was followed by the Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragmatic Hernia (CDH) Workshop on October 6, which emphasized fetoscopic techniques to address congenital diaphragmatic hernia. The workshop series concluded on October 7 with the Spina Bifida Repair Workshop, providing participants with hands-on opportunities to refine their surgical skills in spina bifida repair procedures.

Through these sessions, participants gained practical experience in applying advanced fetomaternal intervention techniques that demand precision, cutting-edge technology, and multidisciplinary collaboration among specialists. As a company committed to advancing healthcare in Indonesia, PT Advance Medicare Corpora actively supported the event by providing medical technology and solutions essential for the success of fetomaternal interventions and treatments.

PT Advance Medicare Corpora’s participation reflects the company’s strong commitment to supporting the development of safe, modern, and mother-and-child-oriented medical devices. The company’s presence also underscores the importance of synergy between the healthcare industry and the medical community in delivering sustainable innovations with broad impact.

The collaboration between RSAB Harapan Kita and UCLH London serves as a strategic step to strengthen the competence of Indonesian medical professionals in the field of fetomaternal medicine. With support from various partners, including PT Advance Medicare Corpora, this event became an important platform for knowledge transfer, research development, and the implementation of medical technologies relevant to national healthcare needs.

PT Advance Medicare Corpora believes that progress in Maternal Fetal Medicine relies not only on medical device innovation but also on collaboration, continuous training, and shared commitment to building an excellent and inclusive healthcare system.

Through its participation in Collaborative Innovations in Maternal Fetal Medicine 2025, PT Advance Medicare Corpora reaffirms its dedication to continuously supporting innovation and strategic partnerships in healthcare — paving the way for a healthier future for mothers, babies, and generations to come.